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ABSTRACT
CONTEXT: Oxidative stress has been increasingly implicated in the pathogenesis and 
progression of cirrhosis. AIMS: We studied oxidative stress in patients with cirrhosis 
by measuring markers reflecting pro-oxidant (serum malondialdehyde-MDA) and 
antioxidant factors (RBC catalase-CAT, superoxide dismutase-SOD and blood reduced 
glutathione-GSH) factors. The level of oxidative stress was also assessed with respect 
to functional compromise of liver, as determined by Child Turcotte Pugh (CTP) scoring.
DESIGN: Case-controlled retrospective study. MATERIALS AND METHODS: Twenty-three 
patients of cirrhosis along with 23 age and sex matched healthy controls were studied. 
Exclusion criteria were concurrent use of anti-oxidant drugs; co-existing diseases like 
DM, CKD; alcohol use, gastrointestinal bleed or blood transfusion within previous 2 
weeks. Besides routine investigations, MDA, CAT, SOD and GSH levels were measured 
and compared with controls. STATISTICAL ANALYSIS: Continuous variables were 
recorded as mean ± SD; ANOVA-f test, followed by Tukey’s test, was used to evaluate 
the significance of difference (P < 0.05) among groups. RESULTS: Mean age of patients 
was 41.04 ± 12.3 yrs. Patients showed a significant increase in MDA {control 3.31 ± 
0.25 (95% CI 3.21-3.41), Child B 6.30 ± 0.4 (95% CI 6.03-6.53), Child C 8.05 ± 0.66 
(95% CI 7.29-8.81) nmol/l} and a significant decrease in levels of SOD {control 845.13 
± 36.44 (95% CI 829.92-860.34), Child B 582.91 ± 42.12 (95% CI 557.45-608.32), 
Child C 489.5 ± 17.66 (95% CI 479.3-499.7) U/gm Hb}, CAT {controls 2.54 ± 0.22 
(95% CI 2.45-2.63), Child B 1.93 ± 0.23 (95% CI 1.72-2.14), Child C 1.46 ± 0.10 (95% 
CI 1.40-1.52) U/ gm Hb} and GSH {controls 6.52 ± 0.25 (95% CI 6.42-6.52), Child B 
3.85 ± 0.18 (95%CI 3.74-3.96), Child C 2.99 ± 0.30 (95% CI 2.82-3.16) mmol/ gm Hb}. 
CONCLUSIONS: Oxidative stress is associated with the development and progression 
of cirrhosis. 
Key words: Humans, cirrhosis, oxidative stress, reactive oxygen species, 
lipid peroxidation
INTRODUCTION
Oxidative stress is defi ned as an imbalance 
between pro-ox idant  and ant iox idant 
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mechanisms in our body, the balance being 
tilted in favor of the former.[1] It has been 
unequivocally implicated in the pathogenesis 
and pathophysiology of many fi broprofi lerative 
d i s e a s e s  s u c h  a s  a t h e r o s c l e r o s i s , 
glomerulonephritis, pulmonary fibrosis and 
cirrhosis.[2]
Previous studies have demonstrated a 
correlation between hepatic and plasma 
glutathione.[3] Glutathione is a tripeptide 
synthesized in the liver which acts as an anti-
oxidant. Erythrocyte antioxidant enzymes, such 
as superoxide dismutase (SOD) and catalase 
(CAT) have been found to be deranged in 
alcoholic liver disease, predisposing them to a 
hemolytic pattern.[4]
Lipoperoxide concentrations, which signify 
increased free radical production, have been 
found to be elevated in liver and serum in 
patients with cirrhosis.[5]
The present study was undertaken to assess 
the oxidative stress with respect to functional 
compromise of liver (as determined by Child-
Pugh scoring), by measuring pro-oxidant 
(serum MDA) and antioxidant (RBC SOD and 
CAT, reduced glutathione-GSH) factors in 
patients with cirrhosis, and comparing them 
with corresponding values in age and sex 
matched controls.
MATERIALS AND METHODS
After informed consent, 23 patients of cirrhosis 
(19 male, 4 female) aged between 24 to 65 
years (median age 46 years), consecutively 
admitted in our department, entered the 
study. An equal number of age and sex 
matched healthy volunteers were recruited. 
Exclusion criteria were concurrent use of 
anti-oxidant drugs; co-existing diseases like 
diabetes mellitus (DM), chronic kidney disease 
(CKD); alcohol use within previous 2 weeks; 
gastrointestinal bleed or blood transfusion 
within previous 2 weeks.
Diagnosis of cirrhosis was based on the clinical 
profile with biochemical and radiological 
investigations and a liver biopsy unless 
contraindicated.
The predominant etiology of cirrhosis in 17 
cases of cirrhosis was alcohol abuse, while 
chronic viral hepatitis was the cause in four 
cases, and two remained of cryptogenic origin. 
Eleven cases were cirrhosis belonging to 
Child’s grade B and 12 had Child’s grade C 
cirrhosis.
Besides routine investigation, biochemical tests 
to measure serum MDA, RBC CAT and SOD, 
and blood GSH were done.
Serum MDA level was measured as an index 
of lipid peroxidation using Satoh calorimetric 
method.[6] This assay is based upon the 
reaction of TBA (thiobarbaturic acid) with 
MDA, one of the aldehyde products of lipid 
peroxidation. The absorbance of the MDA-TBA 
adduct produced was measured at 532 nm 
spectrophotometrically.
The erythrocyte SOD activity was determined 
by the method described by Marklund 
and Marklund, as modified by Nanda and 
Chatterjee.[7,8] This method is based on the 
inhibition of pyrogallol auto-oxidation brought 
about by SOD.
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Erythrocyte catalase (CAT) activity was 
determined by the method of Sinha.[9] This 
is based on the principle that dichromate in 
acetic acid is reduced to chromic acid when 
heated in the presence of H2O, with the 
ultimate production of chromic acetate, which 
is measured at 570 mm.
Reduced glutathione is measured by Teitze’s 
method[10]. This is based on the development 
of yellow color with DTNB (5,5,dithiobis-2-
nitrobenzoic acid), which is measured at 412 mm.
Statistical analysis
The cases were assigned a Child Pugh class. 
The continuous variables were recorded as a 
mean with standard deviation. The signifi cance 
of difference between the various groups was 
calculated using the ANOVA-f test, followed 
by Tukey’s test to ascertain whether the 
differences between the various groups were 
clinically signifi cant (P < 0.05). 
RESULTS
The clinical and biochemical parameters of the 
study subjects were as shown in Table 1.
All the cases had evidence of decompensation 
in the form of asci tes and/or hepat ic 
encephalopathy, refl ecting the fact that cirrhosis 
goes largely undetected in initial stages in our 
country.
The pro-oxidant and anti-oxidant markers in 
the blood of cirrhotics are shown in Table 2, 
with corresponding levels in controls. A further 
comparison refl ecting the differences in these 
values in worsening cases (as determined by 
Child-Pugh scoring) is also shown.
A significant increase in serum MDA value 
in cases was noted (P < 0.05). On further 
assigning the cases as per Child Pugh scoring, 
Child C cirrhosis had a worsening level of 
oxidative stress [Figure 1].
A signifi cant decrease in antioxidant markers, 
Table 1: Clinical and biochemical parameters of the 
study group
Parameter Cases (n = 23) Controls (n = 23)
Age (years) 41.04 ± 12.3  41.89 ± 12.55 
Hb (gm/dl) 10.8 ± 1.85 11.9 ± 1.67
ESR (mm/hr) 21.2 ± 7.4 16.8 ± 8.9
Total Serum Bilirubin 
(mg/dl) 2.59 ± 1.77  0.80 ± 0.15 
Direct Bilirubin (mg/dl) 1.67 ± 1.20  0.43 ± 0.10
Total Protein (gm/dl) 6.57 ± 1.36  5.72 ± 0.34
Serum Albumin (gm/dl) 2.86 ± 0.70  3.76 ± 0.27 
Serum Globulin (gm/dl) 3.71 ± 0.97  1.93 ± 0.11
A/G ratio 0.82 ± 0.27 1.97 ± 0.10
ALT (units/l) 39.86 ± 21.15  33.91 ± 11.41 
Alkaline Phosphatase 
(units/l) 179.57 ± 45.64  132.10 ± 30.26 
Blood Urea (mg/dl) 28.83 ± 11.47  22.34 ± 10.38
S. Total Cholesterol (mg/dl) 142.4 ± 31.6 178.2 ± 28.4
S. Total Glycerides (mg/dl) 104.2 ± 21.4 136.6 ± 25.7
Ascites 18/23 -
Hepatic Encephalopathy 9/23 -
Esophageal Varices 14/23 -
Table 2: Parameters of oxidative stress in cases and controls
 Controls (n = 23) Cases (n = 23) P value Child B (n = 11) Child C (n = 12) P value
Serum MDA  3.31±0.25 7.22±1.06 P=3.65X10-21 6.30±0.49 8.05±0.66 P=7.75X10-07
nmol/ml (95% CI) (3.21-3.41) (6.78-7.66)  (6.03-6.53) (7.29-8.81) 
Erythrocyte SOD  845.13±36.94 534.17±56.91 P=2.34X10-25 582.19±42.12 489.50±17.66 P=7.71X10-07
U/gm Hb (95% CI) (829.92-860.34) (510.38-557.96)  (557.45-608.32) (479.3-499.7)
Erythrocyte Catalase  2.54±0.22 1.68±0.29 P=2.44X10-14 1.93±0.23 1.46±0.10 P=2.19X10-06
U/gm Hb (95% CI) (2.45-2.63) (1.56-1.80)  (1.72-2.14) (1.40-1.52)
Blood Glutathione 6.52±0.25 3.40±0.50 P=1.05X10-28 3.85±0.18 2.99±0.30 P=7.05X10-11
µmol/gm Hb (95% CI) (6.42-6.62) (3.19-3.61)  (3.74-3.96) (2.82-3.16)
MDA: Serum Malondialdehyde (nmol/ml), CAT: Erythrocyte Catalase (units/gm Hb), SOD: Erythrocyte Superoxide Dismutase (units/
gm Hb), GSH: Blood Glutathione (µmol/gm Hb)
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RBC CAT, SOD and blood GSH was noted. On 
grading the cases as per Child Pugh scoring, 
Child C had a signifi cantly reduced level of 
antioxidant markers [Figures 1-4].
DISCUSSION
Liver fi brosis was considered the result of 
repeated steatosis and chronic hepatitis until 
Lewis et al. hypothesized that the individual 
susceptibility of alcoholics to cirrhosis was 
due to variation in free radical scavenging 
enzymes and accumulated free radicals like 
superoxide.[11]
The proposal that oxidative stress has a 
direct causative role in liver fibrogenesis 
was first put forth by Chojkier et al., who 
demonstrated (with cultured fi broblasts) the in 
vitro evidence of a possible molecular linkage 
between enhanced lipid peroxidation and 
induction of collagen gene expression.[12] The 
proposal was subsequently extended to the in 
vivo model when Houglum et al. established 
a close association between liver fibrosis 
induced by iron overload and protein adduct 
epitopes of MDA and 4-hydroxynonenal 













0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25


























Figure 1: Serum Malondialdehyde in Controls and Cases 
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Figure 2: Blood Glutathione in Controls and Cases (Child 
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Figure 3: Erythrocyte SOD in Controls and Cases (Child 
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Figure 4: Erythrocyte Catalase in Controls and Cases 
(Child B and Child C)
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Bedossa et al .  have demonstrated the 
co-localization of increased collagen α-1 
messenger RNA with carbon tetrachloride 
induced lipid peroxidation, by means of in 
situ hybridization and immunohistochemical 
studies in cul tured rat  hepatocytes. [5] 
Muraca et al. demonstrated that antioxidant 
supplementat ion was able to depress 
procollagen α-1 m-RNA over-expression.[14]
A role of oxidative stress in the pathogenesis 
of chronic liver disease has been proposed 
by several authors using animal and human 
studies.[15-17] The aim of our study was to 
assess the changes, if any, in the levels of 
markers reflecting oxidative stress across 
worsening Child scores.
Serum MDA was signifi cantly elevated across 
worsening Child scores. Previous studies, 
in rat and micropig model of experimental 
liver cirrhosis induced by alcohol and iron, 
found increased level of MDA and HNE in 
the liver.[17,18] Iron potentiated fi brogenesis 
was associated with intense and diffuse 
staining for MDA and HNE protein adducts. 
A signifi cant increase in plasma TBARS has 
been noted in the plasma of 38 patients with 
cirrhosis by Yasa et al., with no signifi cant 
difference between erythrocyte thiobarbituric 
acid reactive substances (TBARS) between 
controls and patients.[19] Signifi cant increase 
in the level of plasma MDA in cirrhotics 
was noted by Nalini et al.[20] However, in a 
study by Clot et al., there were no signifi cant 
differences between erythrocyte and plasma 
lipoperoxides in patients with cirrhosis and 
controls.[21]
There  was a  s ign i f i cant  decrease in 
erythrocyte SOD in our cases across 
worsening Child Pugh class. A similar 
trend has been noted in previous studies.
[19,20] However,  Gerl i  et al . ,  in a study 
involving 73 cirrhotics (22 Child A, 30 
Child B, and 21 Child C) and 50 controls, 
demonstrated no signif icant dif ference 
between erythrocyte SOD among various 
groups.[4] The disparities between these 
studies may be explained by dif ferent 
biochemical methods applied and the acute 
condition of the patients, given the fact that 
Child Pugh class may vary if there is any 
precipitating factor such as pharmacological 
incompliance (with a substantial intra class 
variability in patient profi le).
Erythrocyte CAT was signifi cantly lower in 
our cases, as compared to controls. A similar 
trend was noted by Gerli et al., with the 
decline in RBC CAT correlating well with the 
decline in liver function, as assessed by Child 
Pugh classifi cation.[4]
The level of GSH was reduced across 
worsening Chi ld c lass of  c i r rhosis.  A 
signifi cant decline in RBC GSH was noted 
by various authors.[4,20] It should be noted 
that a decline in RBC GSH correlates well 
with decline in blood GSH. It is also pertinent 
to note that investigators have shown that 
decrease in the level of GSH in blood refl ects 
parallel decrease in level of GSH in the liver.
[22]
The b iochemica l  pa thways  by  wh ich 
oxidative stress may cause cell injury are 
lipid peroxidation of membranes, oxidative 
modif ication of proteins and lesions in 
DNA.[1] Studies in intragastric ethanol fed rats 
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have shown that the accumulation of MDA in 
the liver is associated with the development 
of antibodies recognizing protein MDA 
adducts.[23] Steward S et al. have further 
characterized peripheral blood mononuclear 
cell (PBMC) and antibody responses to 
human serum albumin (HSA) adducts to 
MDA.[24] They observed that alcoholic patients 
with cirrhosis had signifi cantly higher cellular 
and humoral immune response to HSA-MDA 
adducts than controls and alcoholic patients 
without cirrhosis, implicating a role of cellular 
and humoral immunity in oxidative stress 
induced cirrhosis.
Hence, var ious mechanisms by which 
oxidative stress may play a role in the 
pathogenesis and progression of chronic liver 
disease are stimulation of hepatic stellate 
cells, Kupffer cells, immune system and 
apoptosis.[25,26]
The chief drawback in our study is a small 
sample size. A correlation between oxidative 
stress in blood and liver biopsy specimens 
was desirable, but for the fact that there 
were obvious contra-indications to perform a 
liver biopsy (such as a deranged coagulation 
profi le, ascites) in many patients. Being a 
cross-sectional study, sequential samples 
were not taken. However, care was taken 
to rule out any precipitating factor like GI 
bleed, acute infection which could infl uence 
oxidat ive st ress,  and the cases were 
relatively stable within their calculated Child-
Pugh class.
CONCLUSIONS 
Our study shows that Child class C cirrhosis 
has greater oxidative stress than Child class 
B cirrhosis suggesting that greater liver 
damage is associated with more oxidative 
stress.
This needs to be corroborated in further 
studies with a larger sample size along with 
serial assessment of oxidative stress and 
its correlation with the (histopathological) 
progression of cirrhosis. This can also serve 
as a background for assessing the role of 
anti-oxidants in preventing the progression 
of cirrhosis.
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